IRAK-4 Kinase Activity Is Required for Interleukin-1 (IL-1) Receptor- and Toll-like Receptor 7-mediated Signaling and Gene Expression
Magdalena Koziczak‐Holbro(Novartis (Switzerland)), Hermann Gram(Novartis (Switzerland))
Cited by 89
Related Papers
A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
|Arthritis & Rheumatism|2006|255
Neutralization of interleukin‐1β modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice
|European Journal of Neuroscience|2009|188
IRAK‐4 kinase activity‐dependent and ‐independent regulation of lipopolysaccharide‐inducible genes
|European Journal of Immunology|2008|36